General Announcement::Board Meeting Intimation for Audited Financial Results For the Quarter & Year Ended March 31, 2020

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Jun-2020 20:34:45
Status
New
Announcement Sub Title
Board Meeting Intimation for Audited Financial Results For the Quarter & Year Ended March 31, 2020
Announcement Reference
SG200617OTHR580H
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
17/06/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, June 26, 2020, inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2020 and to consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2020.

Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from March 31, 2020 till 48 hours after the declaration of financial results of the Company for the quarter and year ended 31st March, 2020.

Attachments

SGX_BM_26062020.pdf
Total size =38K